Citation Information :
Prakash J, Vaibhaw V, Saran K. Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care. Indian J Crit Care Med 2025; 29 (1):6-7.
He RR, Yue GL, Dong ML, Wang JQ, Cheng C. Sepsis biomarkers: Advancements and clinical applications-a narrative review. Int J Mol Sci 2024;25(16):9010. DOI: 10.3390/ijms25169010.
Aramendi I, Burghi G, Manzanares W. Dysglycemia in the critically ill patient: Current evidence and future perspectives. Rev Bras Ter Intensiva 2017;29(3):364–372. DOI: 10.5935/0103-507X.20170054.
Prakash P, Sethi P, Vikram N, Khan M, Gupta Y, Jadon RS, et al. Association of glycemic variability with outcomes in non-diabetic sepsis patients: A prospective observational study. Indian J Crit Care Med 2025;29(1):27–35.
Almagthali A, Alsohimi S, Alkhalaf A, Al Sulaiman K, Aljuhani O. Assessing glycemic variability in critically ill patients: A prospective cohort study comparing insulin infusion therapy with insulin sliding scale. Sci Rep 2024;14(1):10128. DOI: 10.1038/s41598-024-57403-5.
Li X, Zhang D, Chen Y, Ye W, Wu S, Lou L, et al. Acute glycemic variability and risk of mortality in patients with sepsis: A meta-analysis. Diabetol Metab Syndr 2022;14(1):59. DOI: 10.1186/s13098-022-00819-8.
Atamna A, Ayada G, Akirov A, Shochat T, Bishara J, Elis A. High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection. QJM 2019;112(2):101–106. DOI: 10.1093/qjmed/hcy235.
Yao RQ, Ren C, Wu GS, Zhu YB, Xia ZF, Yao YM. Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis. Int J Biol Sci 2020;16(9):1658-1675. DOI: 10.7150/ijbs.43447.
Hryciw BN, Ghossein J, Rochwerg B, Meggison H, Fernando SM, Kyeremanteng K. et al. Glycemic variability as a prognostic factor for mortality in patients with critical illness: A systematic review and meta-analysis. Crit Care Explor 2024;6(1):e1025. DOI: 10.1097/CCE.0000000000001025.
Rytter E, Vessby B, Asgård R, Johansson C, Sjödin A, Abramsson-Zetterberg L, et al. Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects. Br J Nutr 2009;101(10):1423–1426. DOI: 10.1017/s0007114508076204.
Klimontov VV, Saik OV, Korbut AI. Glucose variability: How does it work? Int J Mol Sci 2021 Jul 21;22(15):7783. DOI: 10.3390/ijms22157783.
Gomez AM, Umpierrez GE. Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol 2014;8(5):930–936. DOI: 10.1177/1932296814546025.
DeSalvo D, Buckingham B. Continuous glucose monitoring: Current use and future directions. Curr Diab Rep 2013;13(5):657–662. DOI: 10.1007/s11892-013-0398-4.
